Showing results (1261-1270 of 1,449) with videos related to

Sort By:
Pageof 145
BMC Cancer|June 27, 2019
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivoMirjam Kiener, Lanpeng Chen, Markus Krebs, et al.
BJU International|March 12, 2011
Is there a prostate-specific antigen upper limit for radical prostatectomy?Paulo Gontero, Martin Spahn, Bertrand Tombal, et al.
Science (New York, N.Y.)|September 29, 2007
Rapid emergence of baculovirus resistance in codling moth due to dominant, sex-linked inheritanceS Asser-Kaiser, E Fritsch, K Undorf-Spahn, et al.
Aging Clinical and Experimental Research|September 17, 2021
Iron deficiency and biomarkers of inflammation: a 3-year prospective analysis of the DO-HEALTH trialMaud Wieczorek, Franziska Schwarz, Angélique Sadlon, et al.
Nature|May 25, 2012
The complex of tmRNA-SmpB and EF-G on translocating ribosomesDavid J F Ramrath, Hiroshi Yamamoto, Kristian Rother, et al.
European Journal of Immunology|April 12, 2001
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patchesT W Spahn, A Fontana, A M Faria, et al.
Turk Gogus Kalp Damar Cerrahisi Dergisi|September 21, 2020
Building a patient blood management program in a large-volume tertiary hospital setting: Problems and solutionsSerdar Günaydın, Donat R Spahn, Kanat Özışık, et al.
JMIR Human Factors|January 11, 2024
User Perceptions of Visual Clot in a High-Fidelity Simulation Study: Mixed Qualitative-Quantitative StudyGreta Gasciauskaite, Clara Castellucci, Amos Malorgio, et al.
Journal of Hepatology|January 24, 2026
Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinomaAdam Yopp, Minshan Chen, Ann-Lii Cheng, et al.
Anesthesiology|June 23, 2007
Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-upMichael Zaugg, Lukas Bestmann, Johannes Wacker, et al.
Pageof 145